* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Functional role of c-Jun/PP2B in regulation of gene expression
Tissue engineering wikipedia , lookup
Cell culture wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell encapsulation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cellular differentiation wikipedia , lookup
Signal transduction wikipedia , lookup
Post-translational modification of Sp1 in gene regulation Jan-Jong Hung, Hui-Ling Tsai, and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University Sp1 is a basic transcriptional factor, which binds to the GC-rich region in the promoter of target gene. It is involved in transcription of numerous genes by recruiting other transcriptional factors to the promoters of target genes. Recently, studies reveal that both of DNA binding ability and transactivational activity of Sp1 may be influenced by the post-translational modification of Sp1 such as phosphorylation, glycosylation and acetylation. Therefore, post-translational modification on Sp1 due to interaction with other factors may play an important role in regulation of Sp1 activity. Our previous studies showed that transcription of 12(S)-lipoxygenase is regulated through interaction of c-Jun and Sp1 upon PMA or EGF treatment in A431 cells. Recently, we also found that Sp1 can recruit Hsp90αto the promoter of the 12(S)-lipoxygenase to modulate its transcriptional activity (Hung, et al., 2005). In addition, we also found that the deacetylation of Sp1 is important for the induction of 12(S)-lipoxygenase under PMA treatment and characterized the mechanism (Hung, et al., 2006). The previous studies indicate that Tricostatin A (TSA) is a stimulator of p21WAF1/CIP1. Recently, in our study, we found that HDACs, class I, have the positive effect in expression of p21 WAF1/CIP1 in p53-dependent and -independent cells. The experiments of HDACs overexpression and that of HDACs knockdown in p53-dependent and –independent cells revealed that HDACs were positive effect in the expression of p21 WAF1/CIP1. Furthermore, we studied the mechanism and found that the recruitment of p300 to Sp1 binding region of the p21 WAF1/CIP1 promoter was increased obviously. At last, overexpression of Sp1(K703/A) which can not be acetylated could increase the transcriptional activity of p21 WAF1/CIP1. Taken together, HDACs, class I, may take a positive effect in the regulation of p21 WAF1/CIP1 through Sp1-dependent pathway. However, several points in our studies are still unclear and need study further. First, it is still unclear how many genes in cells were regulated through this mechanism suggested in our study. Second, how to affect the transcriptional activity of 12(S)-lipoxygenase by the Hsp90αthrough the Sp1. Third, there is a high possibility predicted by computer that Sp1 also can be sumoylation, and our preliminary result also revealed that Sp1 can be sumoylated in vitro. Therefore, identification of the sumoylated site(s) in vivo and its role in the gene regulation need to study in the future. Fourth, the regulation between the modification of Sp1 such as phosphorylation, acetylation and sumoylation in cells is still unknown. Functional role of c-Jun/PP2B in regulation of gene expression Ben-Kuen Chen, Chi-Chen Huang, and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University c-Jun/Sp1 interaction is essential for growth factor- and phorbol 12-myristate 13-acetate (PMA)-induced genes expression, including human 12(S)-lipoxygenase, keratin 16, cytosolic phospholipase A2, p21WAF1/CIP1 and neuronal nicotinic acetylcholine receptor 4. We found that the mechanism used to regulate the c-Jun/Sp1 interaction induced by PMA and EGF is mediated by calcineurin (PP2B). Inhibition of calcineurin (PP2B) by using cyclosporin A and PP2B small interfering RNA resulted in attenuating the PMA- and EGF-induced gene expression and c-Jun/Sp1 interaction. PP2B bound and dephosphorylated the phospho-TAM-67 and interacted with c-Jun in PMA-treated cells. To investigate domains involved in the regulation of c-Jun and PP2B interaction, immunoprecipitation and FRET assays were used. Both calmodulin and calcineurin B domains of PP2B were involved in the binding with c-Jun. Since PMA also induced the interaction between c-Jun and PP2B, we want to analyze the function and mechanism involved in the regulation of c-Jun/PP2B complex. PP2B was sumoylated both in PMA-treated cells and in an in vitro enzymatic assay. These results indicated that PMA induced the interaction between c-Jun and PP2B may be through the posttranslational protein modification. In addition, PMA-induced PP2B sumoylation also indicated the possibility of novel function of PP2B in the gene expression. Regulation of gene expression by the VDR/Sp1 complex Yu-Chun Huang, Jing-Yi Chen, Hsuen-Tsen Cheng, Nan-Guai Tsai, Hui-Chiu Chang, and Wen-Chun Hung Graduate Institute of Medicine, Kaohsiung Medical University, and Institute of Biomedical Sciences, National Sun Yat-Sen University Recent studies show that lipophilic hormones may induce expression of target genes in which no hormone receptor response elements are found in their promoter regions. These results suggest that nuclear receptors may physically interact with classic transcription factors to modulate gene expression. In the past four years, we address the functional interaction of vitamin D3 receptor (VDR) and Sp1 in the regulation of gene transcription. The main findings of our study include: (1) VDR may bind indirectly to DNA via interaction with Sp1 transcription factor. In addition, the VDR/Sp1 complex may activate or repress gene transcription via the Sp1 site in the promoter. A number of target genes such as p27 and Skp-2 which expressions are controlled by the VDR/Sp1 complex have been identified. (2) The functional role of VDR and Sp1 in the complex has also been characterized. Our results suggest that Sp1 functions as an anchor protein to bring VDR to the Sp1 binding site in the gene promoter and VDR then recruits the co-activators or co-repressor via its activation domain to stimulate or repress gene transcription. (3) Post-translational modification of VDR may modify the transcriptional activity of this receptor. We find that VDR can be sumoylated and acetylated in vitro and in vivo. Sumoylation of VDR enhances VDR/RXR-mediated transcriptional activation as determined by promoter activity assays. Taken together, our study strongly suggests that VDR may bind with Sp1 to form the VDR/Sp1 complex and modulate gene expression via the Sp1 site in the promoter. Post-transcriptional control of thrombomodulin expression: RNA-binding protein HuR and poly(C)-binding protein 1 bind with the 3’-untranslated region and enhance the messenger RNA stability Joseph T. Tseng, and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University Thrombomodulin (TM), recognized as an important anticoagulant factor, is also expressed by a wide range of tumor cells. Overexpression of wild-type TM decreases cell proliferation in vitro and tumor growth in vivo. The cDNA sequence of TM shows a very long 3’-untranslated region (around 2 Kbps). However, the functional role of this region involved in the regulation of TM expression is not cleared. Here we showed that the post-transcriptional control is an universal mechanism in regulating the TM mRNA expression in HUVEC and A431 cell lines. Under different stimulator treatments, the TM mRNA stability will be enhanced around 2-fold. From the RNA-EMSA experiment, we identified a UC-rich region in the 3’-UTR of thrombomodulin mRNA binding with the protein complex. It indicated this region involved in the regulation of mRNA stability of TM. Furthermore, two major binding proteins HuR, poly(C)-binding protein 1 (PCBP1), were identified by in vitro binding assay. RNA-immunoprecipitation assay indicated that HuR interacted with TM mRNA in vivo and that this interaction increased following stimulator treatments. Suppression of HuR and PCBP1 expression by RNA-interference blocked the accumulation of TM mRNA. These results demonstrated that HuR and PCBP1 coordinated the regulation of TM mRNA stability. Regarding the signal pathway for regulating the TM mRNA stability, Ly294002, a PI3-Kinase inhibitor, was shown to block the stabilization mechanism and enhance the degradation of TM mRNA. Therefore, PI3-Kinase played an important role in mediating the EGF signal induced mRNA stability. Molecular mechanism of EGF-enhanced Aurora-A gene expression in tumor cells Liang-Yi Hung, Minli Wu, Chien-Hsien Lai, and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University Human Aurora-A kinase is highly expressed in a lot of malignant tumor cells and cancer cell lines. According the documents previously reported, the human Aurora-A gene is a potential oncogene. The increased level of human Aurora-A kinase in malignant tumors and cancer cell lines is through the DNA amplification, protein stabilization and transcriptional up-regulation. The detailed mechanism of transcriptional regulation of human Aurora-A gene in tumors is still unclear. In this study, when treated cultured cell lines with EGF, only in EGFR (EGF receptor) overexpressed cell lines (A431, MDA-MB-231, MDA-MB-468 and LS174T), the Aurora-A kinase is up-regulated. Analyze the promoter sequence of Aurora-A gene, there are five predicted ATRSs (the AT-rich sequence, which is the predicted EGFR-recognition sequence) are located upsatream of the promoter region, and three of them contain the predicted STATs (signal transducers and activators of transcription)-binding sequence. The immunoblotting analysis demonstrated the nuclear location of EGFR in these EGFR highly expressed cultured cell lines, except LS174T. Using chromatin immunoprecipaitation (ChIP) assay, we observed significant EGF-induced recruitment of nuclear EGFR to the Aurora-A promoter in A431 cells. DNA-affinity purification assay (DAPA) and ChIP assay further showed the binding of Sp1 in the predicted Sp1-binding site of Aurora-A promoter. Surprisingly, c-Jun is also recruited to the promoter region of Aurora-A which lacks the conserved AP1 binding site. The regulatory mechanism about how EGF-enhanced Aurora-A kinase expression in a lot of malignant tumor cells is under investigated. The significance of macrophage stimulating protein/RON in human bladder carcinogenesis Pei-Yin Hsu1, Nan-Haw Chow2, and Hsiao-Sheng Liu3 1 Institute of Basic Medical Sciences, 2 Department of Pathology, 3 Department of Microbiology and Immunology, College of Medicine, Nation Cheng Kung University The extracellular matrix (ECM) of tissue stroma affects the proliferation, differentiation, and morphogenesis of normal epithelial cells. Moreover, aberration of ECM components, as well as its interaction with epithelial cells, also impinges upon the biological properties of cancer cells. A number of growth factors are deposited in the ECM, including hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). Our previous study revealed the significance of HGF/c-Met signaling pathway in the progression of human bladder cancer. This project thus was designed to explore novel mechanism(s) involved in bladder carcinogenesis as well the potential for cancer therapy. RON, one of the members of c-Met receptor family, is a distinct receptor tyrosine kinase. Previous studies showed that overexpression of RON positively relates to progression of various carcinomas. Our cohort study also revealed that RON-associated signaling involves in cancer progression, and that co-expression of RON and Met plays more important role in bladder carcinogenesis. RON phosphorylation induced by MSP enhances the migration, proliferation and anti-apoptosis of bladder cancer cells. Strikingly, de-phosphorylated forms of both wild-type and truncated RON were detected in the nuclei of cancer cells. We thus propose that nuclear translocalization of RON receptor may play an important role in the progression of bladder cancer. In addition, translocalization of de-phosphorylated RON were found to be mediated by ligand-independent mechanism. The nuclear RON was co-localized with importin 1, importin 1 and de-phosphorylated EGFR. Nevertheless, MSP treatment results in EGFR phosphorylation together with dissociation from nuclear RON, implying a cross-talk between RON and EGFR. The siRNA experiments confirmed the importance of EGFR on nuclear translocalization of RON. We also found that collaboration of RON and EGFR contributes to RON-mediated biological effects in human bladder cancer cells. To clarify the significance of nuclear localization signal (NLS) in the nuclear translocalization of RON, site-directed mutagenesis assay was performed on both Nand C-terminal NLSs of RON. Our preliminary results showed that R306Q at N-terminal and both R1388T and R1389T at C-terminal NLS of RON effectively suppress the translocalization of RON to the nuclei, supporting a classical NLS-dependent mechanism. What is more, both proliferation and anti-apoptosis of NLS mutants were apparently repressed compared with wild-typed RON transfectants, suggesting that nuclear RON might play a crucial role in the proliferation and anti-apoptosis of cancer cells. Aberrant expression of Eps8 in human colorectal tumors Tzeng-Horng Leu Department of Pharmacology, College of Medicine, National Cheng Kung University Our early studies have indicated that: (i) Eps8 (i.e. both p97Eps8 and p68Eps8) overexpression occurs in v-Src-transformed cells; (ii) ectopically expressed p97Eps8 promotes cell transformation of C3H10T1/2 fibroblast; and (iii) ablation of Eps8 expression in v-Src-transformed cell, IV5, reverts its growth advantage character. Thus, p97Eps8 may play an important role in Src-mediated transformation. Indeed, when p97Eps8 expression was either reduced by TSA treatment or specifically knockdown by introducing eps8 siRNA (small interference RNA)-expressing construct into IV5 cells, cell proliferation was significantly inhibited both in vitro and in vivo. To date, the involvement of Eps8 in human cancers is still obscure. In our studies, we observed the overexpression of Eps8 in both human colon cancer cell lines and human colorectal tumor specimens. Interestingly, as compared to cells with low Eps8 expression (i.e. SW480), elevated FAK expression, serum-induced ERK activation, and growth rate are detected in cells with high Eps8 expression (i.e. SW620 and WiDr), implicating the critical role of Eps8 expression in colon cancer formation. Indeed, reduced cell proliferation in culture and tumor growth in nude mice is observed in SW620 cells bearing eps8-siRNA. Surprisingly, a statistically strong correlation between the expression of Eps8 and FAK is also observed in human colon tumor specimens. In addition, Eps8 knockdown of SW620 cells not only decreased FAK expression but also reduced Src-mediated FAK phosphorylation on Tyr-861 and Tyr-397. In agreement with its role in mitogenesis, overexpression of dominant negative FAK (i.e. FRNK) reduced BrdU incorporation of both SW620 and WiDr cells and ectopical expression of FAK in cells with eps8-siRNA restored cellular growth. We thus conclude that Eps8 overexpression in human colon cancer cells facilitates their proliferation by upregulation and activation of FAK. Stat3 activation and pathobiology of lung cancer Wu-Chou Su Department of Internal Medicine, College of Medicine, National Cheng Kung University Lung cancer with its high prevalence, recurrent rate and metastatic potential becomes the leading cause of cancer death in Taiwan. Malignant pleural effusion (MPE) is a poor prognostic sign for patients with non-small cell lung cancer (NSCLC). The generation of MPE is largely regulated by vascular endothelial growth factor (VEGF), and upregulation of VEGF by Stat3 has been observed in several types of tumor cells. Stat3, one of the 7 known STAT (Signal Transducers and Activators of Transcription) family members, is frequently constitutively activated in malignant cells. Activation of Stat3 is involved in regulating many genes such as cell cycle progression, cellular proliferation and survival. In this study, we demonstrate constitutively activated Stat3 in several human lung cancer cell lines and in tumor cells infiltrated in the pleurae of patients with adenocarcinoma cell lung cancers (ADCLC) and MPE. The observations suggest that activated Stat3 plays a role in the pathogenesis of ADCLC. In PC14PE6/AS2 cells, a Stat3-positive human ADCLC cell line, autocrine IL-6 activated Stat3 via JAKs, not via Src kinase. PC14PE6/AS2 cells express higher VEGF mRNA and protein than do Stat3-negative PC14PE6/AS2/dnStat3 cells. In an animal model, PC14P6/AS2/ dnStat3 cells produced no MPE and less lung metastasis than did PC14P6/AS2 cells. PC14PE6/AS2 cells also expressed higher VEGF protein, microvessel density, and vascular permeability in tumors than did PC14P6/AS2/dnStat3 cells. Therefore, we hypothesize that autocrine IL-6 activation of Stat3 in ADCLC may be involved in the formation of malignant pleural effusion by upregulating VEGF. Higher levels of IL-6 and VEGF were also found in the pleural fluids of patients with ADCLC than in patients with congestive heart failure. The autocrine IL-6/Stat3/VEGF signaling pathway may also be activated in patients with ADCLC and MPE. Lung cancer cells with constitutively activated Stat3 are more resistant to cisplatin- and paclitaxel-induced apoptosis. Abrogate the Stat3 signaling by EGCG or AG490 sensitized cells with activated Stat3 to chemotherapeutic drugs, but provide survival advantage to cells in which Stat3 was deactivated firstly by transfection with dn-Stat3. Upon treatment with anti-cancer agents, the activation of Stat3 in PC14PE6/AS2 cells was enhanced at earlier period (around 3 hours), and then declined gradually. The further activation of Stat3 in PC14PE6/AS2 cells by paclitaxel is mediated mainly by mitochondria-respiratory-chain-generated ROS, which then leads to PKC- and Jak activation. We have also investigated expression of a group of proteins in the pleural effusions from lung adenocarcinom, pneumonia and heart failure by ELISA and identified some proteins with pathological significance. Among them, HER-2/neu and IGF-1 have the greatest potential. We have shown that HER2/neu and IGF-1 may play important roles in the pathogenesis of MPE-associated lung adenocarcinoma and may become ideal tumor markers for pleural effusion diagnosis. In proteomics studies, by comparing protein expression patterns of MPE from smoking male and non-smoking female lung cancer patients, we have identified three proteins that are overexpressed in non-smoking females. They are α-1 inhibitor III precursor, apolipoprotein E (APOE), and coatomer protein complex, subunit β (COPB). APOE has been implicated in tumor invasion. By immunohistochemical studies, APOE was found in the cytoplasm of lung adenocarcinoma cells in patients’ pleurae, suggesting it may contribute to pathogenesis of the disease. Further studies on the significance of overexpression of APOE are undergoing. RNA specimens from cancer cells in MPE were extracted and sent for Affymatrix oligonucleotide microarray analyses. Under non-supervised clustering analyses, female non-smokers and male smokers were subdivided into two groups. We also identify a 29-gene-panel that is able to classify these two groups of patients. According to the data generated from the current study, Stat3 activation, together with other oncogenic pathways, contributes to the pathogenesis of MPE formation, lung metastases, and drug resistance of lung cancer cells. ER stress signals induced by HBV pre-S mutants: A novel mechanism for viral carcinogenesis Hui-Ching Wang, and Ih-Jen Su Division of Clinical Research, National Health Research Institutes Hepatitis B viruses (HBV) containing pre-S mutant surface proteins have been linked to the development of HBV-related hepatocellular carcinoma. In past few years, our studies have emphasized on potential oncogenic mechanisms of HBV pre-S mutants. We have identified two major types of pre-S mutants (pre-S1 mutant and pre-S2 mutant) from patients with chronic HBV infection. The pre-S2 mutant surface protein is of particular interest in viewing those hepatocytes harboring pre-S2 mutant proteins usually exhibited clonal proliferation and growth advantages. By double immunofluorescence staining, we have demonstrated that both pre-S mutant proteins were localized in the endoplasmic reticulum (ER) as unfolded proteins leading to ER stress signals. Although ER stress is served as a protective mechanism in response to stress in the ER, our results revealed that ER stress signal may also involve in viral carcinogenesis. ER stress induced by pre-S mutant proteins may lead to oxidative DNA damages and mutagenesis, resulting in genomic instabilities in hepatocytes. In addition, ER stress can stimulate the expression of cyclooxygenase-2 (COX-2), which is essential for the anchorage-independent growth of hepatocytes, through the NF-B and pp38MAPK pathways. Furthermore, pre-S2 mutant protein may enhance cyclin A expression via its specific transactivator functions. In transgenic mice model, pre-S2 mutant protein could induce nodular proliferation and hyperplasia of hepatocytes, supporting a contributing role of hepatocarcinogenesis. Recently, we have explored the oncogenic role of ER stress to the aberrant regulation of centrosome duplication. We have demonstrated that calpain activation upon ER stress may result in N-terminal truncation of cyclin A and its cytoplasmic localization, leading to aberrant centrosome overduplication. Furthermore, our data revealed that pre-S2 mutant protein can induce hyperphosphorylation of RB tumor suppressor via cyclin dependent kinase-2. The pre-S2 mutant protein may also impair functions of p27Kip1 through the interaction with Jun activation domain-binding protein 1 (JAB1). Hence, our results indicated that ER stress signals may contribute to viral carcinogenesis through the induction of impaired cell cycle regulation, centrosome overduplication, oxidative DNA damages, COX-2 expression, RB hyperphosphorylation and degradation of p27Kip1. In conclusion, a novel mechanism for viral carcinogenesis is provided. Isolation and characterization of a small size peptide Zfra that regulates apoptosis by functionally interacting with WOX1 Li-Jin Hsu1, Yee-Shin Lin1 and Nan-Shan Chang2 1 Department of Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan; 2Laboratory of Molecular Immunology, Guthrie Research Institute, Sayre, Pennsylvania, USA We isolated an unusual gene transcript encoding a 31-amino-acid zinc finger-like peptide that regulates apoptosis (named Zfra). Northern blotting and RT/PCR showed the transcript is abundant in spleen but absent in several prostate and breast cancer cells. Presence of Zfra peptide was evidenced by in vitro translation, immunoprecipitation, and isoelectric focusing. Transiently overexpressed Zfra induced apoptosis, and phosphorylation at Ser8 was essential for its apoptotic function. Depending upon the extent of expression, Zfra could either enhance or block the cytotoxic effect of death domain proteins TRADD, FADD and RIP of the TNF and FasL signaling pathways. TNF and UV light induced physical association of Zfra with proapoptotic WOX1 (WWOX/FOR2) and its translocation to the mitochondria, as determined by co-immunoprecipitation, GST pull-down analysis, and immunofluorescence microscopy. Yeast two-hybrid mapping showed that Zfra bound to the N-terminal Tyr33-phosphorylated WW domain of WOX1. WOX1 is a downstream effector of the TNF signaling and capable of enhancing TNF cytotoxicity. Ectopic Zfra blocked phosphorylation and nuclear translocation of WOX1 and p53 and their apoptotic effects in certain cells. In contrast, a Ser8 mutant of Zfra had no blocking effect. Together, Zfra is a novel small size peptide that functionally interacts with downstream effector WOX1 of the TNF and stress pathways. Fas-triggered non-death signaling pathway in tumor formation and autoimmunity Chung-Chen Su, Yu-Ping Lin, and Bei-Chang Yang Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University In the first part of this study, we evaluated the Fas signaling in the presence of tumor/ECM. We demonstrated that the cell contact-induced reduction in the Fas-cross linking-induced apoptosis in T cells is tumor cell line-dependant. Decreases in the characteristics of apoptosis including caspase-9, and -3 activation, loss of plasma asymmetry, cell shrinkage, and loss of mitochondria membrane potential were observed in Jurkat cells upon coculture with glioma cells, which have the ability to suppress apoptosis (manuscript in preparation). In following up the dynamic change of ERK activity, we found that direct cell-cell contact with MCF-7 induced a quick and transient phosphorylation of ERK in Jurkat T cells. However, prolonged cell contact reversed the elevated ERK phosphorylation in Jurkat cells in a protein kinase A (PKA)-dependant way. Furthermore, prolonged contact also enhanced the activity of ERK-specific phosphatases. We concluded that T cell chemokines, will activate RAF/MEK/ERK in T cells. However, prolonged integrin activation by ECM engagement increased cAMP level and activated PKA, which subsequently phosphorylated the Raf at 259 a.a. site leading to inhibition of Raf activity and shut down the MEK/ERK. These findings suggest that anchorage on ECM of tumor can dynamically regulate T cell recruitment. Second, we found that Fas signaling intrinsically activated p38 MAPK pathway by itself to suppress caspase-cascade, which in turn reduced cell death. Inactivation of caspase 8 by Z-IETD eliminated the phosphorylation of p38MAPK in response to Fas treatment. Moreover, phosphor-p38 (pp38) is colocalized with caspase 8. The expression of pp38, reflecting the activity of p38 kinase, was higher in synovial T cells from Rheumatoid arthritis (RA) as compared with that in T cells isolated from normal peripheral blood. Moreover, synovial fluid stimulated the p38 in T cells implicate a role of this kinase in RA (manuscript in preparation). In addition to the novel Fas pathway regulating cell death, we further examined whether caspase-3 may stimulate tumor metastasis. When caspase-3 was introduced into the MCF-7 breast cancer cell line, which was originally caspase-3 deficient, cell motility and lung metastasis were significantly enhanced. In parallel, the caspase-3 expression of A549 lung carcinoma cells was reduced by RNA interference (RNAi) strategy. MCF-7 cells overexpressing caspase-3 did not show significant traits of apoptosis. In addition, the caspase-3 overexpressing MCF-7 cells possessed higher motility and secreted more MMP-2. On the contrary, caspase-3 siRNA reduced motility and invasiveness of A549 cells. By using the in vivo experimental lung metastasis model, we observed that caspase-3 increased the severity of metastasis. In both MCF-7 and A549 cells, we observed a caspase-3 mediated extracellular signal-regulated kinase (ERK) activation, which is independent of caspase-3 activity. In addition, Erk phosphorylation is dominant in caspase-3 mediated cell migration enhancement. Inhibition of Erk activation strongly decreased cell motility. Collectively, we demonstrated that caspase 3 might involve in tumor metastasis (Manuscript in preparation). Low substratum rigidity suppresses FAK397 phosphorylation, but augments Erk1/2 phosphorylation to trigger cell migration Yu-Chih Hsu, Wei-Chun Wei, and Ming-Jer Tang Department of Physiology, College of Medicine, National Cheng Kung University Previous study demonstrated that cells cultured on collagen gel displayed down-regulation of focal adhesion proteins induced by low rigidity. In this study, we found that cells cultured on collagen gel exhibited higher migration capacity than those cultured on collagen gel-coated dishes, suggesting that low substratum rigidity triggers cell migration. Cells cultured on collagen gel displayed enhanced FAK tyrosine phosphorylation similarly with those cultured on collagen gel-coated dishes, with exception that FAKY397 phosphorylation was spared. In contrast, low rigidity induced delayed but persistent phosphorylation of ERK1/2. Inhibition of collagen gel-induced ERK1/2 phosphorylation by MEK inhibitors and ERK2 kinase mutant resulted in cell round up and reduction of collagen gel-induced cell migration. Interestingly, the collagen gel-induced ERK1/2 phosphorylation was present in focal adhesion site, indicating that ERK1/2 activation leads to cell spreading and migration. Moreover, MCD (Methyl-cyclodextrin), lipid raft/caveolae inhibitors, prevented collagen gel-induced phosphorylation of ERK1/2 as well as cell migration. MDCK cells overexpressing FAKY397F mutant exhibited higher levels of ERK phosphorylation than those overexpressing wild type FAK. Taken together, low rigidity induces lipid raft-mediated activation of ERK1/2, which is present in focal adhesion to facilitate cell spreading and migration. Molecular mechanism of ceramide-induced apoptosis: the anti-apoptotic role of lithium Yee-Shin Lin, Chiou-Feng Lin, Chia-Ling Chen, Ming-Shiou Jan, Li-Jin Hsu, Peng-Ju Chien, and Chi-Wu Chiang Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University Ceramide, a product of sphingolipid metabolism functions as intracellular second messenger, may modulate the biochemical and cellular processes in response to various apoptotic stress stimuli. However, the signaling pathways of ceramide-induced apoptosis are not fully defined. Our previous studies showed that sequential activation of caspase-2 and -8 is essential for ceramide-induced mitochondrial apoptosis. Bcl-2 rescues ceramide-induced apoptosis through blockage of caspase-2 activation. Protein phosphatase 2A (PP2A)-mediated Bcl-2 dephosphorylation is involved in caspase-2 activation induced by ceramide. Furthermore, lithium conferred protection against ceramide-induced apoptosis by activation of MEK/ERK and inhibition of caspase-2 and -8. We recently showed that lithium blocked ceramide-induced apoptosis via inhibition of PP2A activity. Ceramide-induced PP2A activation involved methylation of PP2A C subunit, which lithium suppressed. Lithium caused dissociation of PP2A B subunit from the PP2A core enzyme, whereas ceramide caused recruitment of the B subunit. Further study showed a role of glycogen synthase kinase-3 (GSK-3 in ceramide-induced apoptosis, in which GSK-3 acted downstream of PP2A and PI3K/Akt and upstream of caspase-2 and caspase-8. In addition to a direct effect of lithium on GSK-3 as previous known, our study showed that lithium may cause GSK-3 phosphorylation and inactivation through PI3K/PKB- but not ERK-mediated pathway. Microarray analysis showed that ceramide upregulated thioredoxin-interacting protein (TXNIP) expression, whereas lithium downregulated its expression. The involvement of TXNIP in p38 MAPK- and JNK-mediated apoptotic signaling pathways was demonstrated. Interestingly, our recent results showed the involvement of acid sphingomyelinase and ceramide in spontaneous thymocyte apoptosis and lithium may prevent cell death by inhibiting GSK-3 and caspase-2 activation. Taken together, our studies show both transcription-independent and transcription-dependent pathways of ceramide-induced apoptotic cell death, and lithium confers an anti-apoptotic effect in both pathways.